Evidence map›Paper›PMID 41560365›Full record

ArticleInfection control and hospital epidemiology2026

Reducing home infusion CLABSI through a dashboard and toolkit implementation.

Susan Hannum, Jill Marsteller, Ayse P Gurses, Sara E Cosgrove, Ilya Shpitser, Helen Guo, Trung Phung, Opeyemi Oladapo-Shittu, Eili Y Klein, Sara C Keller and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection control and hospital epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Susan HannumDepartment of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID https://orcid.org/0000-0003-1556-8021
Jill MarstellerDepartment of Health Policy and Management, https://ror.org/00za53h95Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-8458-954X
Ayse P GursesDepartment of Health Policy and Management, https://ror.org/00za53h95Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID https://orcid.org/0000-0001-7422-6852
Sara E CosgroveArmstrong Institute of Patient Safety and Quality, https://ror.org/00za53h95Johns Hopkins Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0001-9458-4331
Ilya ShpitserDepartment of Computer Science, Johns Hopkins Whiting School of Engineering, Baltimore, MD, USA.ORCID https://orcid.org/0000-0003-2571-7326
Helen GuoDepartment of Computer Science, Johns Hopkins Whiting School of Engineering, Baltimore, MD, USA.
Trung PhungDepartment of Computer Science, Johns Hopkins Whiting School of Engineering, Baltimore, MD, USA.
Opeyemi Oladapo-ShittuDivision of Infectious Diseases, Department of Medicine, https://ror.org/00za53h95Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Eili Y KleinDepartment of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-1304-5289
Sara C KellerDepartment of Health Policy and Management, https://ror.org/00za53h95Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID https://orcid.org/0000-0001-9660-4367
Home Infusion CLABSI Prevention Collaborative

Funding

AHRQ HHS R01 HS027819
6 · The paper itself

Abstract

objectivesTo evaluate the implementation and effectiveness of a novel home infusion central line-associated bloodstream infection (CLABSI) and home infusion-onset bloodstream infection (HiOB) dashboard and prevention toolkit.

designMixed methods study. SETTING AND

participantsFive home infusion agencies participating in the first CLABSI prevention collaborative.

methodsAgencies uploaded CLABSI and HiOB data to a comparative dashboard. The dashboard started in December 2022 and accepted retrospective data from June 2021. A CLABSI prevention toolkit was made available in June 2024. Using an interrupted time series, we present CLABSI and HiOB rates before and after dashboard and toolkit implementation. We surveyed and interviewed participants about the tools and toolkit, using directed content analysis to analyze the interviews.

resultsAfter dashboard implementation, there was a decrease in CLABSI (-0.23/10,000 home-CVC days, 95% CI -0.28 to -0.18) and HiOB (-0.25/10,000 home-CVC days, 95% CI: -0.31 to -0.18) over time. With toolkit implementation, there was a further decrease in CLABSI (-0.17/10,000 home-CVC days, 95% CI: -0.30 to -0.044) and HiOB (-0.23/10,000 home-CVC days, 95% CI: -0.37 to -0.089) over time. Themes were associated with use of the tools (accessible, adaptable, patient-centered tools; user-friendly education to enhance understanding; barriers identified; tool mismatches; and strategies for tool delivery) and toolkit implementation (structural barriers, user-centered design, collaborative engagement and communication, toolkit used to enhance workforce competency, and concerns related to consistency).

conclusionsImplementation of a dashboard and a CLABSI prevention toolkit were each associated with both CLABSI and HiOB reduction in a collaborative of home infusion agencies.

Identifiers

PMID41560365
PMCPMC12885047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.